Fayette J, Méeus P, Sunyach MP, Thiesse P, Ray Coquard I, Blay JY.
Bull Cancer. 2006 Jan 1;93(1):83-9.
[Article in French]
Hôpital Edouard-Herriot, Service d'oncologie médicale, Pavillon E, 5 place d'Arsonval, 69003 Lyon.
This year, the innovations were numerous in sarcomas. Important progress were accomplished in the search for predictive factors which make it possible to propose to the patient a personalized treatment with the therapeutic ones reduced in the event of good prognosis or on the contrary aggressive steps in the event of bad prognosis. These prognostic factors can be genetic or clinical. Progress were also accomplished in the clinical field with the research of the most adapted therapeutic strategies and of advanced in various drugs of chemotherapy in particular the ET-743. Lastly, research is active and of many ways are tested into preclinic with a detailed attention on the way of the angiogenesis.
Publication Types:
Journal Article